Tricaprilin is under clinical development by Cerecin and currently in Phase II f...
Gene Therapy to Target GD2 for Oncology is under clinical development by Bristol...
Gene Therapy to Target GD2 for Oncology is under clinical development by Bristol...
Nelivaptan is under clinical development by HMNC and currently in Phase II for M...
Darigabat is under clinical development by Cerevel Therapeutics and currently in...
Mankind Pharma has entered into a partnership with Innovent Biologics for licens...
A $4.75m grant will support the development of EIS-12656, which is being studied...
StemVacs-V is under clinical development by Res Nova Bio and currently in Phase ...
Lidocaine is under clinical development by MEDRx and currently in Pre-Registrati...
KGYY-15 is under clinical development by Op-T-Mune and currently in Phase I for ...
Though still below boom levels seen a few years ago, 2024 compares favourably to...
Vertex has won two cystic fibrosis approvals from the FDA, but the agency includ...
GlobalData analysis sees Lilly's investment in UK life sciences as an opportunit...
This seed funding comes after GEMMABio secured $100m in October through a partne...
The FDA initially rejected the marketing application for Alhemo in 2022, asking ...
RAPT Therapeutics and Shanghai Jemincare Pharmaceutical have signed an exclusive...
